The Algorithm of Us

Chapter 3: The Order

Mark's office smelled like fresh coffee and bad news. Claire knew the second she stepped through the door—his smile was already on, the one he saved for investor decks and bad performance reviews.

"Sit down," he said. "Close the door. Actually—leave it open. We're all friends here."

She stayed standing.

"I got your request to the data science team," Mark said, tapping a pen against his desk. "Demographic breakdown of the trial cohort. That's a big pull. Legal wants a paper trail."

"Then give them a paper trail. It's a legitimate question."

"It's a question that reads like an accusation." He set the pen down. "Which is why I've come up with a solution that solves everything at once."

He slid a folder across the desk. Claire didn't touch it.

"The FDA wants supplementary data before full approval. A confirmatory cohort study, prospectively enrolled, balanced. We run it, we hand them a clean binder, everyone goes home happy."

"We already ran the trial. We have the data."

"We have *our* data," Mark said, and something in his voice tightened. "Now we need a second dataset that answers the questions people like that woman at the demo are going to ask. And you're going to co-lead it."

"With who?"

"Dr. Ethan Cole. Mass General. Interventional cardiologist, publishes like a machine. He's already signed on as principal investigator."

Claire felt the floor shift an inch. "You gave him PI before you asked me."

"I gave him a title to get him in the room. You'll run the operational side. Enrollment, protocol, site coordination. You're good at that." Mark picked the folder back up and held it out until she took it. "It's a formality, Claire. Three months of data, a hundred and twenty patients, and we walk into the twenty-eighth with the strongest submission packet in the company's history."

"A hundred and twenty patients is not enough to catch a sex-specific effect even if one exists. You know that. I know that. The FDA knows that."

"The FDA knows we're cooperating in good faith. That's what matters."

"That's what matters," she repeated.

Mark leaned back. The smile didn't waver, but his eyes had gone flat and patient, the way a man looks at a lock he's decided he can open. "You came to me with a concern. This is me addressing it. You wanted data—go get it. You wanted the trial examined—examine it. This is the assignment. Take it or leave it, but if you leave it, I need to know by end of day."

Claire picked up the folder.

Ethan Cole worked out of a corner office at Mass General that was too clean to be real. No family photos, no half-dead plant, no coffee ring. A single monitor, a legal pad, and a pen laid parallel to the edge of the desk. It looked like a hotel room nobody had ever slept in.

He didn't stand when she knocked. He looked up, took her in—blazer, lanyard, the pink ribbon pin clipped just below the logo—and went back to his screen.

"You're Bennett."

"Claire." She sat down across from him without being asked. "You're the PI on the confirmatory study."

"Correct."

"I need to say something first, and I need you to hear it before we start." She opened the folder. "The original trial enrolled seventy-one percent men. The primary endpoint was a composite that doesn't distinguish between obstructive and non-obstructive disease. Women present with different symptoms, different pathophysiology. If we run the confirmatory study to the same spec, we'll reproduce the same blind spot and call it proof."

Ethan set his pen down.

"I read the protocol," he said. "I read the original dataset. I've done this before."

"Then you see the problem."

"I see a cohort that's male-weighted because women are underrepresented in cardiac trials the way they're underrepresented in everything." He said it flatly, without heat. "That's a recruitment problem, not an algorithm problem."

"It's both. The model was trained on that cohort. It learned from it."

"The model learned to predict adverse events. It does that well." He finally turned to face her fully. "Seventy-one percent isn't seventy-one percent by accident, Bennett. It's seventy-one percent because enrolling women in cardiac studies is expensive and slow. They screen-fail. They're older, they present later, they have comorbidities that muddy the endpoints. You want to fix a model, you fix the training data. You want to fix the training data, you need ten years and a budget nobody's going to give you."

"So we ship the bias and hope nobody notices."

"We ship the *tool*—" his voice sharpened for the first time, "—that catches MIs that would otherwise walk out of the ER. That's not nothing. That's tens of thousands of catches a year."

"Unless it's a woman, and it tells her she's fine."

He was quiet. A nurse's cart rattled past in the hallway.

"That's an emotional argument," he said at last.

"It's a mortality argument."

"It's an emotional argument *dressed* as a mortality argument. You have one anecdote and a demographic table." He picked his pen back up. "I've buried patients too, Bennett. That's the job. What you feel about it has to stay out of the math or the math stops working."

Claire stood. She could feel the heat in her face and hated that she could feel it.

"One patient," she said. "Yolanda Alvarez. Thirty-nine. Her sister came to my demo and told a room full of investors that the algorithm sent her home. I have her pin on my collar because nobody at this company has said her name since."

Ethan looked at the pin. Then at her face.

"Alvarez," he said. Something moved behind his eyes—too fast to name, and gone. "I saw the FDA letter. There was a reported adverse event in the trial."

"There were three."

"I saw one."

"Then somebody edited the file." She dropped the folder on his desk. "You want to run a formality. Fine. But I'm not signing anything until I've seen every adverse event report in the original dataset, including the ones that got dropped."

"You don't have clearance for that."

"Then get it for me. You're the PI."

He studied her for a long moment. She could see him doing the math—the cost of fighting her, the cost of appeasing her, the cost of the launch slipping a quarter and coming out of his consulting fee. Grumpy, efficient, transactional.

"Friday," he said. "I'll get you the AE binder. In exchange, you stop calling it a formality's job. I run the confirmatory cohort my way—recruitment, sites, protocol. You handle the operational mess and keep your mouth shut in front of the sponsor until we have data worth fighting over."

"That's not a partnership. That's a gag order."

"It's a division of labor by competence." He turned back to his screen. "You're good at chasing things down. I'm good at getting studies finished. We both want to walk into the twenty-eighth with something real."

"Do we?"

For a second—barely a second—the mask slipped. He looked tired in a way that had nothing to do with the hour.

"I had a patient," he said. "Two years ago. Forty-two. Went to a community ER, got triaged low-risk, discharged, died in her car in the parking lot. Different hospital, different tool. But I read every report afterward for a year, looking for the thing I missed." He looked up. "You want me to care about your algorithm. Fine. I care. But I've been down this road, and it doesn't end with you feeling better."

"What does it end with?"

"Data. Or nothing." He slid a signature page toward her—the collaborative agreement, pre-drafted, waiting. "Sign it or don't."

Claire picked up the pen. Her hand wasn't shaking, which surprised her. She signed.

"I'll have the AE binder to you by Friday," Ethan said, without looking up. "Don't be late to the kickoff."

She was at the door when he spoke again.

"Bennett."

She turned.

"You should know what you're signing up for," he said. "Mark called me before he called you. He told me you were emotional and that I should manage you."

Claire held his gaze. "And what did you tell him?"

"That I'd see for myself." He went back to his screen. "Friday. Nine a.m. Don't bring the pin."

Claire closed the door behind her and stood in the corridor for a moment, the folder heavy under her arm. Seventy-one percent men. Three adverse events, one in the file. Mark had called Ethan first. Mark had warned him about her.

She took out her phone and texted the data science lead, the one who hadn't answered in four days: *still waiting on the enrollment breakdown. send to personal email.*

Then she texted a number she'd saved that morning and hadn't used: *Mrs. Alvarez. I'm still investigating. I need the name of the doctor who discharged Yolanda.*

The reply came in under a minute.

*Dr. Ethan Cole was on call that night.*

Claire stared at the screen until the corridor lights hummed loud enough to hear.

Back to book

Sign in or create an account

Sign in with Google to keep your library and reading progress on every device.

Continue with Google

By continuing you agree to our Terms and Privacy.

Chapter 3: The Order · The Algorithm of Us · Lumen Reads